Phencyclidine Use Disorder 521
Note: Withdrawal symptoms and signs are not established for phencyclidines, and so this
criterion does not apply. (Withdrawal from phencyclidines has been reported in animals
but not documented in human users.)
Specify if:
In early remission:  After full criteria for phencyclidine use disorder were previously
met, none of the criteria for phencyclidine use disorder have been met for at least
3 months but for less than 12 months (with the exception that Criterion A4, “Craving,
or a strong desire or urge to use the phencyclidine,” may be met).
In sustained remission:  After full criteria for phencyclidine use disorder were previ-
ously met, none of the criteria for phencyclidine use disorder have been met at any time
during a period of 12 months or longer (wit h the exception that Criterion A4, “Craving,
or a strong desire or urge to use the phencyclidine,” may be met).
Specify if:
In a controlle d environment:  This additional specifier is used if the individual is in an
environment where access to phencyclidines is restricted.
Coding based on current severity:  Note for ICD-10-CM codes: If a phencyclidine intoxica-
tion or another phencyclidine-induced mental disorder is also present, do not use the codes
below for phencyclidine use disorder. Instead, the comorbid phencyclidine use disorder is in-
dicated in the 4th character of the phencyclidine-induced disorder code (see the coding note
for phencyclidine intoxication or a specific phencyclidine-induced mental disorder). For ex-